Clinical Trials for Cancer Type: Breast

24 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ALLIANCE-A011502 (CIRB) A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial Open
ECOG-EAY131 (CIRB) Molecular Analysis for Therapy Choice (MATCH) Open
NRG-BR002 (CIRB) A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer Open
NSABP-B-51 (CIRB) A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy Open
SWOG-S1207 (CIRB) Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer Open
SWOG-S1418 (CIRB) A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (>pN1mic) After Neoadjuvant Chemotherapy Open
UCI-10-24 ATHENA Breast Health Network Open
UCI-10-39 Predicting pathological response within the first week of neoadjuvant chemotherapy using functional parameters measured with Diffuse Optical Spectroscopic Imaging (DOSI) Open
UCI-12-10 Development of a Quantitative Tissue Optical Index of Breast Density for Prediction of Hormone Therapy Response Open
UCI-14-25 Plasma Exosome Concentration in Cancer Patients Undergoing Treatment Open
UCI-14-49 Mapping Breast Cancer Survivorship and the Survivor Institutional Interface Open
UCI-14-62 Breast Tumor Oxygenation During Exercise Open
UCI-14-67 A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel with Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting Open
UCI-14-81 Mi Salud, Mi Vida: A Self-Discovery Tool for Latina Breast Cancer Survivors Open
UCI-14-85 Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System Open
UCI-14-86 Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System Open
UCI-15-83 Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging in a Multi-Center Setting Open
UCI-16-02 Breast and Cervical Cancer Survivorship in Zambia: Quality of Life, Social Support, and the Role of HIV/AIDS Open
UCI-16-23 Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer [The WISDOM Study (Women Informed to Screen Depending On Measures of Risk)] Open
UCI-16-96 A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors Open
UCI-17-05 Understanding Intratumoral Heterogeneity Using Single Cell RNA Sequencing Open
UCI-17-08 Peripheral Hormonal Profile in Women with Breast Lesions Open
UCI-17-22 Epigenetic markers for pesticide exposure and cancer risk Open
UCI-95-29 Measurement of Breast Tissue Optical Properties Open